[Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004341:Drug Evaluation; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010973:Platelet Adhesiveness / Q000187:drug effects; D014280:Triglycerides / Q000097:blood
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D008055:Lipids; D009539:Nicotinic Acids; D014280:Triglycerides; D002784:Cholesterol
Klinische Erfahrungen mit SPN 40150 bei Hyperlipidämie und arterio-sklerotischen Durchblutungsstörungen.